Cargando...
4CPS-183 Off-label rituximab in neurology patients
BACKGROUND: Rituximab is an anti-CD20 monoclonal antibody. Its off-label use has increased in the management of a variety of neurologic diseases. PURPOSE: To describe rituximab prescriptions in the Neurology Department, and evaluate the scientific evidence in off-label indications to rationalise its...
Guardado en:
| Publicado en: | Eur J Hosp Pharm |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Group
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535240/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.273 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|